SHELLY CARLTON: Open Payments
NPI 1275088254 · MUSKOGEE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$318 in 18 payments from 9 companies in 2025. Trend: 2023 $490 · 2024 $162 · 2025 $318
Food & beverage: $318
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $75 |
| Novo Nordisk Inc | 2 | $49 |
| Astellas Pharma US Inc | 2 | $42 |
| ABBVIE INC. | 2 | $38 |
| Lilly USA, LLC | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Alkermes, Inc. | 1 | $17 |
| Intra-Sana Laboratories | 1 | $14 |
Products named: AUSTEDO XR, Veozah, VRAYLAR, Ozempic, MOUNJARO, CAPLYTA, AIRSUPRA, VIVITROL.
Industry payments across OK — which companies pay providers there.
